NCT06090578 · RECRUITING
TabCAT Brain Health Assessment in Primary Care
This trial is testing a tablet-based brain health screening tool called TabCAT in primary care clinics. The goal is to see whether using it leads to better detection of cognitive impairment and dementia compared to usual care. It is a pragmatic trial, meaning it runs in real clinic settings rather than a controlled lab. Phase NA here means it is not a drug trial — it is evaluating a clinical workflow tool.
You may qualify if
- Patient with at least one encounter at an intervention clinic during the intervention period
- Age 18+ (limited to 65+ for primary analyses)
You're excluded if
- Patients under the age of 18.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-10-31